What is Cognitive FX?
Cognitive FX operates at the intersection of advanced neuroscience and clinical medicine, specializing in evidence-based treatments for complex brain injuries. The company addresses critical gaps in traditional care for patients suffering from concussions, post-concussion syndrome, and viral-induced neurological impairments. By utilizing fMRI-targeted therapy, the organization provides a data-driven, personalized recovery path for patients who have historically struggled to find relief through conventional medical channels. With a multidisciplinary team of 14 doctors and therapists, the clinic has established a high-performance model, reporting that 77% of its patients achieve a return to normal cognitive function post-treatment. This measurable success rate serves as the cornerstone of their market authority in the neuro-recovery sector.
How much funding has Cognitive FX raised?
Cognitive FX has raised a total of $520K across 2 funding rounds:
Debt
$150K
Debt
$370K
Debt (2020): $150K with participation from PPP
Debt (2021): $370K led by PPP
Key Investors in Cognitive FX
PPP
Public-Private Partnership
What's next for Cognitive FX?
With the infusion of this recent capital, Cognitive FX is poised to scale its intensive treatment programs to meet the rising global demand for specialized brain injury care. The strategic roadmap likely involves expanding clinical capacity and investing in further research to refine its fMRI-based diagnostic and therapeutic tools. As the company transitions into this next phase of development, the focus will remain on scaling its operational infrastructure while maintaining the high-touch, personalized care that defines its brand. By solidifying its position as a leader in neuro-rehabilitation, Cognitive FX is well-positioned to influence the future of brain health, potentially setting new industry standards for measurable patient outcomes in the treatment of POTS and other complex neurological conditions.
See full Cognitive FX company page
